Follow up idea, see related idea
After 5 wave impulse down and two month accumulation phase below IPO level sideways,
expect trend reversal into bull market, the downtrend channel got broken and tested on weekly timeframe.
The first human got crispered in china. USA will follow in 2017, I speculate on public awareness and solid growth, maybe hype.
In case of bull market, we got the possible pitchfork
After 5 wave impulse down and two month accumulation phase below IPO level sideways,
expect trend reversal into bull market, the downtrend channel got broken and tested on weekly timeframe.
The first human got crispered in china. USA will follow in 2017, I speculate on public awareness and solid growth, maybe hype.
In case of bull market, we got the possible pitchfork
הערה:
and back above IPO!!! i love it <3
הערה:
look for rsi breakout into new highs, consolidation above 18$ would confirm reversal.
הערה:
Wyckoff scenario
הערה:
wyckoff playing out nicely, can buy on dips for reaccumulation 16-17$ range
trailing stop below pitchfork, this stock keeps giving for weeks now with great volatility
trailing stop below pitchfork, this stock keeps giving for weeks now with great volatility
הערה:
made a little indicator to compare EDIT price with the BTK biotech index
At ipo the indicator is 0, values below 0 indicates that EDIT is undervalued compared to biotech index, values over 0 indicates EDIT is overvalued compared to biotech index. Also showing the MA20 of this line (black).
At ipo the indicator is 0, values below 0 indicates that EDIT is undervalued compared to biotech index, values over 0 indicates EDIT is overvalued compared to biotech index. Also showing the MA20 of this line (black).
הערה:
more media attention
www.wired.co.uk/arti...-technique-explained
www.wired.co.uk/arti...-technique-explained
הערה:
crispr again in the news after
הערה:
crispr again on all news sites after National Academy of Sciences releases Report "Human Genome Editing: Science, Ethics, and Governance"
הערה:
CRISPR patent goes to Broad Institute of Cambridge -> EDIT www.technologyreview...-to-broad-institute/
הערה:
pitchfork still intact!
wyckoff scenario also playing out as expected :-)
wyckoff scenario also playing out as expected :-)
הערה:
Editas Medicine announces that its offering of 4M shares priced at $22.50 per share.
seekingalpha.com/new...-prices-90m-offering
resistance 0.5 fib keylevel at 28.20
Support 20.00-22.50
seekingalpha.com/new...-prices-90m-offering
resistance 0.5 fib keylevel at 28.20
Support 20.00-22.50
הערה:
doubled my position here
הערה:
this should be a bear trap, new chart on linear scale
